Latest Insider Transactions at C4 Therapeutics, Inc. (CCCC)
This section provides a real-time view of insider transactions for C4 Therapeutics, Inc. (CCCC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of C4 Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of C4 Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2020
|
William Mckee Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,263
+50.0%
|
$99,997
$19.0 P/Share
|